Related Experiment Video
Updated: May 29, 2025

05:46
Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
356
Non-Surgical Correction of Dermatochalasis Using Microplasma
Journal of Drugs in Dermatology : JDD
|February 6, 2025
Summary
Microplasma effectively reduces redundant upper eyelid skin in dermatochalasis patients. This non-surgical treatment option demonstrated significant aesthetic improvements with minimal adverse effects in clinical trials.
Area of Science:
- Dermatology
- Aesthetic Medicine
- Medical Technology
Background:
- Dermatochalasis involves excess upper eyelid skin, a common aging concern.
- Surgical blepharoplasty is the standard treatment, but non-surgical alternatives are sought.
- This study evaluates microplasma as a novel non-surgical approach for dermatochalasis.
Purpose of the Study:
- To assess the safety and efficacy of microplasma treatment for dermatochalasis.
- To investigate the histological effects of microplasma on skin.
- To evaluate patient-reported outcomes and aesthetic improvements.
Main Methods:
- Pre-clinical in vivo studies on porcine skin using histology.
- A prospective clinical trial involving 13 subjects with dermatochalasis.
- 1-2 microplasma treatments administered over 4-16 weeks, with blinded photographic and questionnaire assessments.
Main Results:
- Porcine studies showed expected skin ablation, dermal coagulation, and healing responses.
- Blinded evaluations indicated significant improvement in the Dermatochalasis Scale (P<0.01).
- Patients reported aesthetic improvements, and no serious adverse events occurred.
Conclusions:
- Microplasma offers a safe and effective non-surgical solution for reducing redundant upper eyelid skin.
- The treatment provides significant aesthetic benefits with a favorable safety profile.
- Microplasma represents a viable alternative to surgical blepharoplasty for dermatochalasis.

